BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37968007)

  • 1. Assessing the burden of HPV-related head and neck cancers in mainland China: protocol of a nationwide, multisite, cross-sectional study.
    Wang W; Song C; Su Z; Kothari S; Chen YT; Liu Y; Wu SY; Panchal R; Morais E; Zhang SK; Yin J; Qiao YL; Roberts C
    BMJ Open; 2023 Nov; 13(11):e073277. PubMed ID: 37968007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers.
    Morais E; Kothari S; Chen YT; Roberts CS; Gómez-Ulloa D; Fenoll R; Lara N; Pavón MÀ; Waterboer T; Mehanna H; Giuliano AR; Mirghani H; Alemany L
    Contemp Clin Trials; 2022 Apr; 115():106631. PubMed ID: 34838716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the prevalence of non-cervical human papillomavirus infection in mainland China (PROGRESS-Plus): protocol of a national cross-sectional study.
    Wang W; Kothari-Talwar S; Roberts C; Lu Q; Lara N; Panchal R; Morais E; Chen YT; Qiao Y; Cui F
    BMJ Open; 2023 Feb; 13(2):e065749. PubMed ID: 36731925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
    Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
    J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of HPV-Positive Tumors in Europe and in the World.
    Castellsagué X; Mena M; Alemany L
    Recent Results Cancer Res; 2017; 206():27-35. PubMed ID: 27699527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Human Papillomavirus and Co-Infection with Epstein-Barr Virus in Oral and Oropharyngeal Squamous Cell Carcinomas.
    Makvandi M; Jalilian S; Faghihloo E; Khanizadeh S; Ramezani A; Bagheri S; Mirzaei H
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3931-3937. PubMed ID: 36444607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The "ALARM" study.
    Agelaki S; Boukovinas I; Athanasiadis I; Trimis G; Dimitriadis I; Poughias L; Morais E; Sabale U; Bencina G; Athanasopoulos C
    Cancer Med; 2024 Feb; 13(3):e6916. PubMed ID: 38247106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infection of human papillomavirus and head and neck cancer].
    Song C; Zhang SK; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):39-43. PubMed ID: 36709118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POP-Brazil study protocol: a nationwide cross-sectional evaluation of the prevalence and genotype distribution of human papillomavirus (HPV) in Brazil.
    Wendland EM; Caierão J; Domingues C; Maranhão AGK; de Souza FMA; Hammes LS; Falavigna M; Hilgert JB; Hugo FN; Bessel M; Villa LL; Benzaken AS
    BMJ Open; 2018 Jun; 8(6):e021170. PubMed ID: 29880568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
    Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
    Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
    Combes JD; Franceschi S
    Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
    Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
    BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human papillomavirus in archival head and neck cancer in the eastern Inner Mongolian Autonomous Region, China.
    Wu E; An G; Wu R; Tang Y; Li Q; Wang J; Ling Y; You J
    Tumori; 2020 Oct; 106(5):369-377. PubMed ID: 32066343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
    Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
    Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
    Morais E; El Mouaddin N; Schuurman S; De A
    Vaccine; 2021 Sep; 39(39):5461-5473. PubMed ID: 34452775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus-Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review.
    Okerosi S; Mokoh LW; Rubagumya F; Niyibizi BA; Nkya A; Van Loon K; Buckle G; Bent S; Ha P; Fagan JJ; Ng D; Aswani J; Xu MJ
    JCO Glob Oncol; 2023 Jan; 9():e2200259. PubMed ID: 36730877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STOP HPV study protocol: a nationwide case-control study of the association between oropharyngeal cancer and human papillomavirus (HPV) infection in Brazil.
    Wendland EM; Kops NL; Comerlato J; Horvath JDC; Bessel M; Sperb D; Pimenta C; de Souza FMA; Mendes Pereira GF; Falcetta FS
    BMJ Open; 2020 Jan; 10(1):e031602. PubMed ID: 32001492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of India.
    Kumar R; Rai AK; Das D; Das R; Kumar RS; Sarma A; Sharma S; Kataki AC; Ramteke A
    PLoS One; 2015; 10(10):e0140700. PubMed ID: 26473489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.